Treatment success for infantile hemangioma: Associated therapy is better
Topic overview
Meta-analysis demonstrates that combining beta-blockers (propranolol or timolol) with laser therapy for infantile hemangiomas achieves significantly better treatment outcomes than either modality alone, without increasing adverse events. Combined therapy may also reduce overall treatment duration compared to monotherapy.
Key takeaways
- Combined beta-blocker and laser therapy for infantile hemangiomas is significantly more effective than either treatment alone.
- Oral propranolol plus laser showed 5-6x better odds of treatment success compared to monotherapy in meta-analysis.
- Topical timolol combined with laser therapy demonstrated superior efficacy without increased adverse events versus monotherapy.
- Combination therapy may shorten overall treatment duration compared to single-modality approaches.
- Safety profile of combined beta-blocker and laser treatment is comparable to monotherapy, with no significant increase in adverse reactions.
Comments